Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Ashish C. Bhatia MD, FAAD Associate Editor

Jane M. Grant-Kels MD, FAAD Advisory Board

See All Experts

featured

Published in Dermatology

Journal Scan / Research · October 06, 2016

Secukinumab Is Superior to Ustekinumab in Clearing Moderate to Severe Plaque Psoriasis Up to 1 Year

Journal of the American Academy of Dermatology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Andrew Blauvelt MD, MBA

Journal of the American Academy of Dermatology

Secukinumab Is Superior to Ustekinumab in Clearing Skin of Subjects With Moderate-to-Severe Plaque Psoriasis Up to 1 Year: Results From the CLEAR Study

J Am Acad Dermatol 2016 Sep 20;[EPub Ahead of Print], A Blauvelt, K Reich, TF Tsai, S Tyring, F Vanaclocha, K Kingo, M Ziv, A Pinter, R Vender, S Hugot, R You, M Milutinovic, D Thaçi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Secukinumab Is Superior to Ustekinumab in Clearing Moderate to Severe Plaque Psoriasis Up to 1 Year

Additional Info

Secukinumab Is Superior to Ustekinumab in Clearing Skin of Subjects With Moderate-to-Severe Plaque Psoriasis Up to 1 Year: Results From the CLEAR Study

Further Reading

Effectiveness of Treatment With Deucravacitinib in Patients With Plaque, Generalized Pustular, or Erythrodermic Psoriasis

Factors Associated With Maintenance of Clinical Response After Reducing the Dosing Frequency of Tralokinumab in Patients With Moderate to Severe Atopic Dermatitis

Long-Term Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Hidradenitis Suppurativa

Association Between Metformin Use and the Risk of Non-Melanoma Skin Cancer

Allergic Contact Dermatitis Owing to Personal Care Product Use Among Men

Provider-Related Factors Associated With an Increased Likelihood of Performing Benign Skin Biopsies

Effects of Comorbidities on Wound Healing in Patients With Pyoderma Gangrenosum

Non-Steroidal Treatment Approaches for the Management of Patients With Atopic Dermatitis

Prevention of Occupational Contact Dermatitis Among Firefighters

Risk of Disease-Specific Mortality Among Patients With Melanoma In Situ Treated With Mohs Micrographic Surgery vs Wide Local Excision

Refusal of Surgery Among Patients With Cutaneous Melanoma: Clinical Predictors and Effect on Melanoma-Specific Survival Outcomes

Recently Updated